13F HOLDINGS REPORT
Velan Capital Investment Management LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001848809-25-000005
Total Value
$101.2M
Positions
53
Other Managers
0
Confidential Omitted
No
Holdings (53)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HERONTHERAPEUTICSINC | HRTX | 6,986,744 | $14.5M | 14.29% |
| 2 | VERONAPHARMAPLC | 925050106 | 95,000 | $9.0M | 8.88% |
| 3 | JASPERTHERAPEUTICSINC | JSPRW | 1,188,500 | $6.6M | 6.52% |
| 4 | PROTARATHERAPEUTICSINC | TARA | 2,139,000 | $6.5M | 6.40% |
| 5 | ZEVRATHERAPEUTICSINC | ZVRA | 715,000 | $6.3M | 6.22% |
| 6 | PRAXISPRECISIONMEDICINESI | PRAX | 149,334 | $6.3M | 6.20% |
| 7 | TOURMALINEBIOINC | 89157D105 | 319,080 | $5.1M | 5.04% |
| 8 | CIDARATHERAPEUTICSINC | 171757206 | 100,000 | $4.9M | 4.81% |
| 9 | ALUMISINC | ALMS | 1,620,846 | $4.9M | 4.80% |
| 10 | ARVINASINC | ARVN | 500,000 | $3.7M | 3.64% |
| 11 | SCPHARMACEUTICALSINC | 810648105 | 917,668 | $3.5M | 3.45% |
| 12 | REZOLUTEINC | RZLT | 750,000 | $3.3M | 3.30% |
| 13 | LIQUIDIACORPORATION | LQDA | 239,260 | $3.0M | 2.94% |
| 14 | MINERALYSTHERAPEUTICSINC | MLYS | 174,600 | $2.4M | 2.33% |
| 15 | SUTROBIOPHARMAINC | STRO | 3,060,000 | $2.2M | 2.16% |
| 16 | INSPIREMDINC | NSPR | 904,029 | $2.1M | 2.03% |
| 17 | PERSPECTIVETHERAPEUTICSINC | CATX | 500,000 | $1.7M | 1.70% |
| 18 | REPLIMUNEGROUPINC | REPL | 183,083 | $1.7M | 1.68% |
| 19 | TELABIOINC | TELA | 747,410 | $1.4M | 1.43% |
| 20 | JASPERTHERAPEUTICSINC | JSPRW | 245,328 | $1.4M | 1.34% |
| 21 | NEKTARTHERAPEUTICS | NKTR | 50,000 | $1.3M | 1.28% |
| 22 | VIRIDIANTHERAPEUTICSINC | VRDN | 86,500 | $1.2M | 1.19% |
| 23 | TOURMALINEBIOINC | 89157D105 | 74,809 | $1.2M | 1.18% |
| 24 | UPSTREAMBIOINC | UPB | 107,000 | $1.2M | 1.16% |
| 25 | ELEDONPHARMACEUTICALSINC | ELDN | 338,973 | $918,617 | 0.91% |
| 26 | EDESABIOTECHINC | EDSA | 437,500 | $888,125 | 0.88% |
| 27 | AVALOTHERAPEUTICSINC | AVTX | 154,972 | $773,310 | 0.76% |
| 28 | EDESABIOTECHINC | EDSA | 250,000 | $507,500 | 0.50% |
| 29 | TENAXTHERAPEUTICSINC | TENX | 83,333 | $479,998 | 0.47% |
| 30 | CORBUSPHARMACEUTICALSHLDGS | CRBP | 59,000 | $407,100 | 0.40% |
| 31 | KIORAPHARMACEUTICALSINC | KPHMW | 122,223 | $352,002 | 0.35% |
| 32 | PROTAGONISTTHERAPEUTICSINC | PTGX | 3,700 | $204,499 | 0.20% |
| 33 | CYTOMXTHERAPEUTICSINC | CTMX | 75,000 | $170,250 | 0.17% |
| 34 | NURIXTHERAPEUTICSINC | NRIX | 10,000 | $113,900 | 0.11% |
| 35 | GERONCORP | GERN | 70,000 | $98,700 | 0.10% |
| 36 | WAVELIFESCIENCESLTD | WVE | 15,000 | $97,500 | 0.10% |
| 37 | LARIMARTHERAPEUTICSINC | LRMR | 33,000 | $95,370 | 0.09% |
| 38 | GOSSAMERBIOINC | GOSS | 75,000 | $92,250 | 0.09% |
| 39 | PROQRTHRAPEUTICSNV | N71542109 | 45,000 | $91,800 | 0.09% |
| 40 | VENTYXBIOSCIENCESINC | 92332V107 | 40,000 | $85,600 | 0.08% |
| 41 | ERASCAINC | ERAS | 65,000 | $82,550 | 0.08% |
| 42 | ALECTORINC | ALEC | 55,000 | $77,000 | 0.08% |
| 43 | TERNSPHARMACEUTICALSINC | TERN | 20,000 | $74,600 | 0.07% |
| 44 | DESIGNTHERAPEUTICSINC | DSGN | 20,000 | $67,400 | 0.07% |
| 45 | CONTEXTTHERAPEUTICSINC | CNTX | 100,000 | $65,520 | 0.06% |
| 46 | OVIDTHERAPEUTICSINC | OVID | 160,000 | $52,784 | 0.05% |
| 47 | IMMIXBIOPHARMAINC | IMMX | 25,000 | $51,750 | 0.05% |
| 48 | VYNETHERAPEUTICSINC | VYNE | 30,000 | $49,500 | 0.05% |
| 49 | ACLARISTHERAPEUTICSINC | ACRS | 32,700 | $46,434 | 0.05% |
| 50 | 4DMOLECULARTHERAPEUTICSIN | FDMT | 12,000 | $44,520 | 0.04% |
| 51 | PYXISONCOLOGYINC | PYXS | 40,000 | $44,000 | 0.04% |
| 52 | PMVPHARMACEUTICALSINC | PMVP | 35,000 | $37,100 | 0.04% |
| 53 | NEXTCUREINC | NXTC | 45,000 | $20,700 | 0.02% |